Cerclage After Full Dilatation Caesarean Section
CRAFT
An Investigation Into the Role of Previous in Labour Caesarean Section in Future Preterm Birth Risk and Management Strategies
2 other identifiers
interventional
1,000
1 country
1
Brief Summary
CRAFT-OBS: Observational Study; To evaluate subsequent pregnancy risk of preterm birth in women with a history of previous caesarean in established labour. This prospective study using clinically acquired cervical length and quantitative fetal fibronectin data will help establish a predictive model of preterm birth \<34 weeks and \<37 weeks. CRAFT-RCT: Randomised controlled trial arm; To assess treatment for short cervix in women at high risk of preterm birth following a caesarean section at full dilatation CRAFT-IMG: Imaging sub-study; To aid understanding of micro and macrostructural features within the cervix which predisposes to preterm birth in women with a previous full dilatation caesarean section. This will use MRI and an advanced transvaginal ultrasound protocol and to assess if structural changes can be visualised in the cervix.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started Oct 2019
Typical duration for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
September 26, 2019
CompletedFirst Posted
Study publicly available on registry
October 1, 2019
CompletedStudy Start
First participant enrolled
October 2, 2019
CompletedPrimary Completion
Last participant's last visit for primary outcome
April 1, 2022
CompletedStudy Completion
Last participant's last visit for all outcomes
October 1, 2022
CompletedJuly 28, 2021
July 1, 2021
2.5 years
September 26, 2019
July 27, 2021
Conditions
Outcome Measures
Primary Outcomes (2)
CRAFT-OBS: Number of participants with spontaneous preterm birth rate < 37 weeks gestation
Up to 42 weeks
CRAFT-RCT: Number of participants with spontaneous preterm birth <34 weeks gestation
Up to 42 weeks
Secondary Outcomes (18)
CRAFT-OBS: Short-term pregnancy and neonatal outcomes, including a composite of neonatal death and morbidity.
Up to 48 weeks
CRAFT-OBS: Number of participants with adverse perinatal outcome, defined as a composite outcome of death (antepartum/intrapartum stillbirths plus neonatal deaths prior to discharge from neonatal services)
Up to 48 weeks
CRAFT-OBS: Number of participants who deliver <34 weeks gestation
Up to 42 weeks
CRAFT-OBS: Gestation at delivery
Up to 42 weeks
CRAFT-OBS: Late miscarriage (14+0-23+6 weeks) rate
Up to 42 weeks
- +13 more secondary outcomes
Study Arms (2)
Transvaginal cerclage
ACTIVE COMPARATORActive monitoring
NO INTERVENTIONInterventions
Transvaginal cerclage is inserted in women with a high risk of preterm birth. However it is unknown whether this alongside cervical length monitoring improves the incidence of preterm birth. The cerclage is inserted under regional analgesia.
Eligibility Criteria
You may qualify if:
- Pregnant women under 23+6 weeks gestation with a history of previous caesarean section in labour.
- Singleton pregnancy.
- Willing and able to give informed consent (with or without interpreter).
You may not qualify if:
- Under 16 years of age.
- Inability to give informed consent.
- Previous caesarean section carried out before labour.
- Women who have been commenced on management with progesterone, a cerclage or arabin pessary as part of their care or another research study
- CRAFT-RCT:
- Pregnant women up to 23+6 weeks gestation with a history of FDCS.
- Short cervix (\<=25mm) on transvaginal ultrasound scan.
- Women with persistent fresh vaginal bleeding evident on speculum examination.
- Women with visible fetal membranes evident on speculum examination or open cervix on ultrasound scan.
- Women with severe abdominal pain/evidence of sepsis (as judged by attending clinician).
- Known significant congenital or structural or chromosomal fetal abnormality.
- Suspected or proven rupture of the fetal membranes at the time of recruitment.
- CRAFT-IMG
- Pregnant women between 14+0 and 23+6 weeks gestation with a history of FDCS.
- Contraindications to MRI, e.g. claustrophobia, BMI \>40 kg/m2 (due to technical limitations of scanner) or a women with a non-MRI compatible metallic implant.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Guy's and St Thomas' NHS Foundation Trustlead
- King's College Londoncollaborator
- University College, Londoncollaborator
Study Sites (1)
Guy's and St Thomas' Hospital NHS Foundation Trust
London, SE1 7EH, United Kingdom
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- PREVENTION
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
September 26, 2019
First Posted
October 1, 2019
Study Start
October 2, 2019
Primary Completion
April 1, 2022
Study Completion
October 1, 2022
Last Updated
July 28, 2021
Record last verified: 2021-07
Data Sharing
- IPD Sharing
- Will not share